Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration TARRYTOWN, N.Y., Jan. 13, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced an agreement to jointly develop an innovative antibody to the Platelet Derived Growth Factor Receptor Beta as a potential combination therapy ... (more)
http://ift.tt/1hmVgwq
http://ift.tt/1hmVgwq
No comments:
Post a Comment